購物車(0)
購物車(0)
Advice from a Japanese Authority on Immuno-Oncology about how to Enhance Your Immunity Swiftly and Build a Robust Body
Immune Deficiency, Antineoplastic Drugs, and Radiotherapy Are Unfavorable for Cancer Treatment
The First Ever Exposition of “Hydrogen Immunotherapy”
．The Globally First Attempt to Fight Cancer by the Application of Hydrogen, with over 400 Evidence-Based Cases Included
．Significant Prolongation of the Life Expectancy of Many End-Stage and Recurrent Cancer Patients
Hydrogen Activates Human Immune Cells！
The probability of developing cancer has increased significantly with the extension of the average human lifespan. There is an increasing number of literature demonstrating the diverse bioactivities inducible by oxyhydrogen inhalation, including anti-inflammatory, anti-reactive oxygen species (ROS), and antineoplastic effects.
Evidence has also suggested that hydrogen may be used to mitigate the side effects of traditional chemotherapy, or to inhibit the growth of cancer cells and xenotransplanted tumor. In addition, the application of oxyhydrogen in the treatment of COVID-19 may not only reduce the symptom associated with difficulty breathing, but also exhibit the critical anti-inflammatory effect.
This book is the first collection of the research and comments made by a Japanese immuno-oncologist on “hydrogen immunotherapy.” Apart from the promising and extensive application in clinical treatment, hydrogen is helpful to prolong the healthy lifespan when used in daily care and health maintenance as well.
Recommended by
Dr. He-Chang Kuo, M.D.│professor of the School of Medicine of Chang Gung University
Dr. Ming-Hsien Huang, M.D.│vice superintendent of E-Da Cancer Hospital
Dr. Wen-Chang Lin, Ph.D.│chairman of Epoch Energy Technology Co. and Ota Hydrogen Biotech
作 者 簡 介
作者簡介
Junji Akagi
Immuno-oncologist
Specialist and supervising physician of Japan Surgical Society
Specialist and supervising physician of Japan Society of Gastroenterological Surgery
Accredited physician for cancer treatment in Japan
Accredited physician of the Society for Integrative Medicine Japan
Member of council of the Society for Integrative Medicine Japan and Director of the Kumamoto affiliate
Director general of International Society for Hydrogen Medicine and Biology
Dr. Akagi was born in Sasebo City, Nagasaki Prefecture in 1954. After graduating from the College of Liberal Arts of Kyushu University, he attended the School of Medicine of the former Miyazaki Medical University. Intended to become an ideal physician, Dr. Akagi spent day and night studying during his stay at the School of Medicine. In order to gain knowledge and experience, he had even studied in the US at the National Cancer Institute of the National Institutes of Health. While abroad, Dr. Akagi realized the very fact that in every three cancer patients who came to seek treatment, one would eventually die. Although he was disappointed by the situation, he has since striven to rescue t
Immune Deficiency, Antineoplastic Drugs, and Radiotherapy Are Unfavorable for Cancer Treatment
The First Ever Exposition of “Hydrogen Immunotherapy”
．The Globally First Attempt to Fight Cancer by the Application of Hydrogen, with over 400 Evidence-Based Cases Included
．Significant Prolongation of the Life Expectancy of Many End-Stage and Recurrent Cancer Patients
Hydrogen Activates Human Immune Cells！
The probability of developing cancer has increased significantly with the extension of the average human lifespan. There is an increasing number of literature demonstrating the diverse bioactivities inducible by oxyhydrogen inhalation, including anti-inflammatory, anti-reactive oxygen species (ROS), and antineoplastic effects.
Evidence has also suggested that hydrogen may be used to mitigate the side effects of traditional chemotherapy, or to inhibit the growth of cancer cells and xenotransplanted tumor. In addition, the application of oxyhydrogen in the treatment of COVID-19 may not only reduce the symptom associated with difficulty breathing, but also exhibit the critical anti-inflammatory effect.
This book is the first collection of the research and comments made by a Japanese immuno-oncologist on “hydrogen immunotherapy.” Apart from the promising and extensive application in clinical treatment, hydrogen is helpful to prolong the healthy lifespan when used in daily care and health maintenance as well.
Recommended by
Dr. He-Chang Kuo, M.D.│professor of the School of Medicine of Chang Gung University
Dr. Ming-Hsien Huang, M.D.│vice superintendent of E-Da Cancer Hospital
Dr. Wen-Chang Lin, Ph.D.│chairman of Epoch Energy Technology Co. and Ota Hydrogen Biotech
作 者 簡 介
作者簡介
Junji Akagi
Immuno-oncologist
Specialist and supervising physician of Japan Surgical Society
Specialist and supervising physician of Japan Society of Gastroenterological Surgery
Accredited physician for cancer treatment in Japan
Accredited physician of the Society for Integrative Medicine Japan
Member of council of the Society for Integrative Medicine Japan and Director of the Kumamoto affiliate
Director general of International Society for Hydrogen Medicine and Biology
Dr. Akagi was born in Sasebo City, Nagasaki Prefecture in 1954. After graduating from the College of Liberal Arts of Kyushu University, he attended the School of Medicine of the former Miyazaki Medical University. Intended to become an ideal physician, Dr. Akagi spent day and night studying during his stay at the School of Medicine. In order to gain knowledge and experience, he had even studied in the US at the National Cancer Institute of the National Institutes of Health. While abroad, Dr. Akagi realized the very fact that in every three cancer patients who came to seek treatment, one would eventually die. Although he was disappointed by the situation, he has since striven to rescue t
